January 12, 2012 – Access to capital, a burdensome and uncertain regulatory environment, and lack of innovation and productivity in research and development are the biggest threats to the biomedical industry's growth over the next five years, according to biomedical company CEOs surveyed by CHI-California Healthcare Institute, BayBio and PwC US.
January 12, 2012 – Masimo announced U.S. Food and Drug Administration (FDA) 510(k) clearance and full market commercial launch of the Masimo Pronto-7—a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb), SpO2, pulse rate, and perfusion index.
January 12, 2012 — Simbionix USA Corp. recently announced advanced virtual reality (VR) simulators that can communicate in Chinese, Japanese and Russian, in addition to English.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
January 12, 2012 — A project led by The American Society of Echocardiography (ASE) will utilize the latest technological innovations in the field to bring cardiovascular ultrasound to rural India.
January 12, 2012 — An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans.
January 11, 2012 — HeartWare International, Inc. and Dualis MedTech GmbH, a subsidiary of AVRA Surgical, Inc., announced an agreement to develop ventricular assist devices with wireless, transcutaneous energy transfer system (TETS) technology exclusively for HeartWare.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 11, 2012 – Siemens Healthcare has announced that the version 2.0 of the Acuson SC2000 volume imaging ultrasound system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
January 9, 2012 – Janssen Research and Development, LLC (JRD) announced today that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of Xarelto (rivaroxaban), an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular events in patients with acute coronary syndrome (ACS).
January 9, 2012 - Uninsured patients, and those with Medicaid, receive far less imaging services than those with private insurance during emergency department (ED) visits, according to a study in the January issue of the Journal of the American College of Radiology.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 9, 2012 - GE Healthcare announced the Brivo NM615 has received clearance from the U.S. Food and Drug Administration (FDA).
January 9, 2012 – A registry that includes every patient in Sweden having percutaneous coronary intervention (PCI) found use of newer generation drug-eluting stents (DES) is associated with lower rates of restenosis, stent thrombosis and mortality than older DES and bare-metal stents.
January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac perfusion radiotracer with a list of actions to bring the product back to market.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million. Following successful approval of a U.S. Food and Drug Administration (FDA) pre-market approval (PMA), an additional $100 million will be paid.
January 6, 2012 - Bracco Imaging SpA has acquired Swiss Medical Care (SMC), a Swiss company headquartered in Lausanne and engaged in research, production and marketing of automated systems for the administration of contrast agents for diagnostic imaging.
January 6, 2012 – A study led by researchers from the University of North Carolina at Chapel Hill School of Medicine has identified a molecular pathway that leads to this abnormal blood clotting and have turned it off using a popular class of cholesterol-lowering drugs; statins.
January 12, 2012
